Markets entered this week on edge — a familiar posture in 2026 — as investors balanced a steady stream of earnings reports against the backdrop of persistent macro noise, ongoing trade policy uncertainty, and a Fed still in a holding pattern. On balance, the prints were constructive, with more beats than misses and a handful of guidance raises that suggest corporate America is navigating the environment with more confidence than the indices might imply. As always, I want to stress that these quarterly data points are most useful as context — not catalysts. Think of earnings as periodic health checks that reveal whether a company’s competitive position and structural growth story remain intact, not as triggers for immediate portfolio action.
JPMorgan Chase delivered another strong quarter, beating on both earnings per share ($5.94 vs. $5.49 expected) and revenue ($50.5B vs. $45.9B expected) by a wide margin. The size of the revenue beat was notable and reflects the breadth of JPMorgan’s business mix — investment banking, markets, and asset management all appear to have contributed. The one item worth watching is the trimmed net interest income guidance, which signals that management sees some pressure on the spread between what the bank earns on loans and what it pays on deposits. This is a well-understood dynamic given the rate environment, but it bears monitoring as a potential headwind into the second half of the year. American Express similarly impressed, posting earnings of $4.28 per share against a $4.06 estimate and revenue of $13.6B against a $12.4B expectation — confirming that the high-spending consumer segment remains remarkably resilient.
UnitedHealth Group had a standout quarter across the board. Earnings came in at $7.23 versus a $6.59 estimate, revenue reached $111.7B against an expectation of $109.4B, and management raised full-year adjusted EPS guidance to above $18.25. For long-term holders, the guidance raise is the most meaningful data point — it signals that management sees the current trajectory as sustainable, not a one-quarter anomaly. In a healthcare landscape where medical cost trends have been a persistent concern industrywide, UNH’s ability to beat and raise is a differentiator worth noting.
Boeing remained the most closely watched turnaround story on the industrial side. The company reported a loss of $0.20 per share, well above the $0.75 loss the street was bracing for, and revenue of $22.2B beat the $21.8B estimate. It would be easy to headline this as a “beat,” but the more important frame is whether cash flow recovery remains on track toward the $1–3B full-year target that management reaffirmed. Boeing’s challenge has never been demand — commercial aviation demand is intact — it has been execution, quality control, and the pace at which the production system can be stabilized. This week’s print suggests incremental progress, but this remains a story measured in years, not quarters.
Intel’s quarter demands a closer look before reading too much into the headline beat. The company reported $0.29 in earnings per share against a $0.02 estimate — an enormous percentage beat — but revenue of $920.7M came in slightly below the $945.9M expectation. Beats of this magnitude against a very low baseline can reflect cost actions and accounting items as much as fundamental recovery. Guidance was raised, with second-quarter revenue expected in the range of $13.8–14.8B, which was encouraging. Intel remains in a multiyear restructuring, and the path to relevance in leading-edge logic and AI accelerators is long. This quarter is a step forward, not a finish line.
Texas Instruments posted an impressive quarter as well, earning $1.68 per share against a $1.40 estimate and growing revenue to $4.83B versus the $4.60B expected. Critically, management raised guidance for the fiscal second quarter, with an earnings range of $1.77–2.05 that sits above street estimates. For a company as cyclically sensitive as TI, a beat-and-raise suggests that the industrial and automotive semiconductor markets — the backbone of TI’s revenue base — may be stabilizing after an extended inventory correction. This is an early but constructive signal worth tracking across the broader chip supply chain.
Industrials and Defense
The group was broadly solid. GE Aerospace delivered earnings of $1.86 versus $1.60 expected and revenue of $11.6B versus $10.6B, reaffirming guidance while noting results are trending toward the high end of the range — a subtle but meaningful signal of confidence. RTX Corporation topped estimates on both lines and raised full-year adjusted EPS guidance to $6.70–6.90, reinforcing the durability of defense and aerospace demand. Northrop Grumman and Honeywell posted modest beats, consistent with their steady-execution reputations, though Honeywell’s revenue came in slightly below expectations — a detail to watch given ongoing business portfolio restructuring. Lockheed Martin was the outlier in the group, missing on both EPS ($6.44 vs. $6.79 expected) and revenue ($18.0B vs. $18.2B), while reaffirming full-year GAAP EPS guidance around the $29.80 midpoint. Union Pacific held its own with a small beat, reaffirming mid-single-digit EPS growth for the year. Vertiv Holdings rounded out the group on a strong note, matching revenue estimates and raising full-year adjusted EPS guidance to $6.30–6.40 — a continued endorsement of data center infrastructure demand. GE Vernova beat modestly on both lines and raised its full-year EBITDA margin outlook to 12–14%, a positive development for those watching the electrification and grid investment thesis.
Financials
Beyond JPMorgan and American Express, the financial sector produced a clean set of results. Goldman Sachs earned $17.55 per share against a $16.37 estimate, with revenue of $17.2B modestly ahead of the $17.0B expectation. Goldman reaffirmed guidance, consistent with the firm’s practice of not providing formal EPS targets. Northern Trust posted a strong beat as well, earning $2.71 versus a $2.37 estimate on revenue of $2.21B. Blackstone was the one mild miss, with earnings of $1.36 slightly below the $1.38 estimate, though revenue of $3.62B came in well ahead of the $3.42B expectation — and management provided no formal guidance, consistent with prior practice. The overall picture across financials is one of underlying strength, with the NII trimming at JPMorgan the main item to monitor going forward.
Healthcare
UnitedHealth’s strong quarter was the headline, but Thermo Fisher Scientific and Danaher also contributed positively. Thermo Fisher earned $5.44 versus $5.24 expected, beat on revenue, and raised full-year revenue and EPS guidance — a well-rounded beat for a company viewed as a bellwether for life sciences capital spending. Danaher beat on earnings ($2.06 vs. $1.94 expected) but revenue came in just shy of the $6.0B estimate at $5.95B, and guidance was raised modestly. Taken together, healthcare is not without pockets of softness, but the large-cap diversified names are executing well.
Technology
Outside of Intel and Texas Instruments, the technology group was mixed. IBM delivered a modest earnings and revenue beat, reaffirming full-year constant-currency revenue growth of more than 5% — a sign that its software and consulting pivot continues to produce results. Lam Research beat on both lines and raised its fourth-quarter fiscal 2026 guidance above street estimates, consistent with a gradual semiconductor equipment recovery. Pegasystems was the notable disappointment, missing earnings by a wide margin ($0.46 vs. $0.68 expected) and coming in below revenue estimates as well, though management noted cloud annual contract value momentum remains intact. SAP reported revenue of $18.9B against an $18.8B estimate, with EPS and guidance pending following its late-April release. Nokia posted a small earnings beat but light revenue, reaffirming full-year operating profit guidance.
Energy, Utilities, and Materials
Halliburton beat on both earnings ($0.55 vs. $0.50 expected) and revenue ($5.4B vs. $5.3B expected), with no formal guidance change — a stable result consistent with steady oilfield services demand even as energy prices remain volatile. NextEra Energy posted earnings of $1.09 against a $0.94 estimate but revenue came in at $6.7B, below the $7.3B expectation — though the regulated utility’s full-year adjusted EPS guidance of $3.92–4.02 was reaffirmed, suggesting the miss was driven by timing or mix rather than a structural issue. Alcoa missed modestly on both earnings and revenue, with no formal guidance change. Procter & Gamble beat on both lines, though management guided toward the low end of the full-year EPS range of $6.83–7.09 — a modest adjustment that likely reflects input cost and foreign exchange headwinds rather than demand softness. Philip Morris beat on earnings and raised full-year guidance on a foreign-exchange-neutral basis, though reported revenue came in just slightly below estimates.
United Airlines was the one travel name in the mix, beating on both earnings and revenue while lowering full-year adjusted EPS guidance to $7–11 from a prior range of $12–14 — a significant reduction that reflects margin pressure and demand uncertainty in the second half of the year. It is a useful reminder that consumer-facing travel businesses, while operationally recovering, remain sensitive to macro confidence in a way that defense or utilities do not.
On balance, this was a week that reinforced a familiar theme: the fundamentals of most large-cap businesses remain intact, but the dispersion in outcomes — and particularly in forward guidance — is widening. Companies with structural demand drivers, pricing power, and balance sheet flexibility are executing well. Those with execution challenges, margin pressure, or demand sensitivity are being held to a higher standard by the market. For long-term investors, the key takeaway is not which stocks moved on Friday morning, but whether the companies you own continue to validate the thesis that justified the position in the first place.
Portfolio Topics:
Understanding Guidance: Why It Often Matters More Than the Beat
If there is one lesson embedded in a week like this, it is that the market frequently cares more about guidance than it does about the reported quarter. A company can beat earnings by 15% and still see shares fall — as we have seen in prior periods with high-multiple technology names — if the forward outlook disappoints. Conversely, a company can miss a quarter and trade higher if management communicates confidence in the trajectory ahead.
For long-term investors, this dynamic creates both opportunity and noise. In the short term, guidance-driven reactions can push high-quality businesses to prices that are more attractive than the reported results alone would suggest. In the long term, the accumulation of guidance raises from a well-run business is one of the clearest signals that management has earned credibility and that the competitive moat is holding.
When reviewing earnings with your advisor, it is worth asking not just whether a company beat or missed, but what the guidance implies about the next twelve to twenty-four months — and whether that picture is consistent with the long-term thesis.
Rebalancing in Volatile Markets
Periods of elevated dispersion — where certain sectors or positions move significantly in either direction — create natural rebalancing opportunities that are easy to overlook when markets feel uncertain. When a position grows meaningfully as a percentage of a portfolio due to outperformance, it may be worth trimming back toward the target allocation, even when the underlying business remains compelling. Conversely, when a high-conviction holding pulls back due to a short-term guidance revision rather than a fundamental deterioration, it can present an opportunity to add at improved levels.
Rebalancing is one of the most behavioral disciplines in investing — it requires selling what has recently done well and adding to what has recently lagged, which runs counter to instinct. Approached systematically and in coordination with your advisor, it is one of the more durable ways to manage risk and maintain alignment with your financial plan over time.
Disclosure
This material is provided for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security or investment strategy. The views expressed are those of the author as of the date of publication and are subject to change without notice.
The author is a financial professional and may hold positions in, or manage client accounts that hold positions in, the securities discussed. Such holdings are subject to change at any time without notice. While the author strives to present information in a fair and balanced manner, no representation is made that this commentary is free from bias, and readers should be aware of potential conflicts of interest.
The information presented is derived from publicly available sources believed to be reliable, but accuracy and completeness are not guaranteed. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal.
This commentary does not take into account the investment objectives, financial situation, or particular needs of any specific person. No advisor-client relationship is created by the receipt or review of this material. Readers should consult with a qualified financial, legal, or tax professional before making any investment decisions.













